Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

VALIDATE II Study: Observational Trial Evaluating Elevated Factor VIII Related Labs in Multiple Sclerosis Relapse as a Marker for Incomplete Recovery

NCT05926167 is registered in ClinicalTrials.gov with Dignity Health Medical Foundation as lead sponsor.

NCT NCT05926167
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05926167 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
VALIDATE II Study: Observational Trial Evaluating Elevated Factor VIII Related Labs in Multiple Sclerosis Relapse as a Marker for Incomplete Recovery
Lead sponsor
Dignity Health Medical Foundation
Phase
Observational
Overall status
Unknown status
Start date
September 12, 2023
Completion date
December 31, 2024
Enrollment
9 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

multiple sclerosis, relapse